Markup of 21 Bills, Subcommittee on Health
Date:
The Subcommittee on Health of the Committee on Energy and Commerce held an open markup session of 21 bills on Wednesday, November 15, 2023 at 10:00 am. The markup will take place in the John D. Dingell Hearing Room, 2123 Rayburn House Office Building.
Key Documents
Opening Statement from Ranking Member Pallone as prepared for delivery
Opening Statement from Subcommittee Ranking Member Eshoo as prepared for delivery
Livestream
Legislation
H.R. 5372, the Expanding Seniors’ Access to Lower Cost Medicines Act of 2023
H.R. 2880, the Protecting Patients Against PBM Abuses Act
H.R. 5393, To amend title XVIII of the Social Security Act to ensure fair assessment of pharmacy performance and quality under Medicare part D, and for other purposes
H.R. 5385, the Medicare PBM Accountability Act
H.R. 4881, To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program
H.R. 5389, the National Coverage Determination Transparency Act
H.R. 133, the Mandating Exclusive Review of Individual Treatments (MERIT) Act
H.R. 5396, the Coverage Determination Clarity Act of 2023
H.R. 5371, the Choices for Increased Mobility Act of 2023
H.R. 5380, To amend title XVIII of the Social Security Act to increase data transparency for supplemental benefits under Medicare Advantage
H.R. 3842, Expanding Access to Diabetes Self-Management Training Act of 2023
H.R. 5397, the Joe Fiandra Access to Home Infusion Act of 2023
H.R. 6366, To amend title XVIII of the Social Security Act with respect to the work geographic index for physician payments under the Medicare program, and to revise the phase-in of clinical laboratory test payment changes under such program
H.R. 6369, To amend title XVIII of the Social Security Act to extend incentive payments for participation in eligible alternative payment models
H.R. 5555, the DMEPOS Relief Act of 2023
H.R. 6371, the Provider Reimbursement Stability Act of 2023
H.R. 6364, the Medicare Telehealth Privacy Act of 2023
H.R. 1352, the Increasing Access to Biosimilars Act of 2023
H.R. 1691, the Ensuring Patient Access to Critical Breakthrough Products Act of 2023
Subcommittees
Issues:Health